Clinical Trials Directory

Trials / Completed

CompletedNCT02356393

Serum Magnesium Levels in Desalination Tap Water and Outcomes in Acute Myocardial Infarction Patients

The Effect of Magnesium Serum Levels on Clinical Outcomes in Patients With Acute Myocardial Infarction by Considering Desalination Drinking Water Levels Patients Fed From.

Status
Completed
Phase
Study type
Observational
Enrollment
150 (actual)
Sponsor
Sheba Medical Center · Other Government
Sex
All
Age
35 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Association between serum magnesium and clinical outcome in patients with acute MI (AMI) with 1 year follow-up in 300 patients in regions supplied by desalinated drinking water (DSW) (Sheba MC) and 150 patients in regions with non-desalinated drinking water (DW) (Nahariya MC).

Detailed description

Extensive seawater desalination in Israel may decrease magnesium in drinking water (DW), causing hypomagnesemia and adverse health effects. We study the association between consumption of desalinated drinking water (DSW) and serum magnesium in acute MI (AMI) patients, Subjects 35-75 years of age with the first AMI will be prospectively recruited during 1 year from 2 regions; the Departments of Cardiology at the Sheba Medical center (300 patients, predominantly served by DSW) and the Nahariya Medical Center (150 patients, served by non-DSW). Questionnaire will be developed to collect data on demographic variables (at home and work), water and beverages consumption habits (tap water, mineral water), dietary sources of Mg and Mg supplementations. Mg levels will be measured in DW from the patients' homes and in their serum on admission.

Conditions

Timeline

Start date
2015-05-01
Primary completion
2023-12-01
Completion
2023-12-01
First posted
2015-02-05
Last updated
2023-12-12

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02356393. Inclusion in this directory is not an endorsement.